CKD and VHD share metabolic, inflammatory, and fibrotic pathways, worsening each other's progression and complicating management. An integrated care model involving nephrologists, cardiologists, and ...

Society is fascinated with health, fitness and longevity. This obsession has spawned a multi-million pound industry centered ...

Steatotic liver disease (SLD), mainly encompassing metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic dysfunction and ALD (MetALD), ...

A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...

Exercise-induced angiogenesis and lymphangiogenesis offer promising anti-aging benefits by improving vascular and immune ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for major cardiovascular events and for all-cause mortality, according to a new analysis of real-world ...

Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...

For standard GLP-1 usage, Roslin said that patients are started with a low dose and titrated up to clinical effect. That ...

A comprehensive review published in Brain Medicine demonstrates that disruptions in gut microbiota composition are closely linked to sleep disturbances across multiple disorders, including insomnia, ...